Hard To Treat Diseases, Incorporated Announces: Appellant's Brief Filed in U.S. Court of Appeals
Thursday December 29, 9:02 am ET
DELRAY BEACH, FL--(MARKET WIRE)--Dec 29, 2005 -- Hard To Treat Diseases, Incorporated (HTTD) (Other OTC:HTDS.PK - News) announces that HTTD's Initial Brief of Appellant was filed yesterday in the U.S. Court of Appeals for the Eleventh Circuit.
The brief clearly states the Company's position and addresses the major issues to be corrected; including:
1) Important areas in which the Trial Court erred
2) Why HTTD is entitled to the rights to Tubercin
3) How Shinn and Knight breached their duties, mislead investors and
injured HTTD's shareholders
The Company remains fully confident in the judiciary and legal process, since our case is now with a panel of judges in the U.S. Court of Appeals.
The complete text of the brief and exhibits will be posted this week on HTTD's website at: www.htdsotc.com
HTTD's CEO, Colm King, states, "The Company will continue to protect its shareholders' rights and become a respected biotech. Our intense focus is to negotiate a deal with a major biotech/drug company in early 2006 and attain the goals of benefiting patients and HTTD's shareholders."
Cautionary Note Regarding Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this news release may contain or constitute forward-looking statements. These forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions of the Private Securities Litigation Act of 1995, Hard To Treat Diseases, Inc. provides the following cautionary statement identifying important factors which, among others, could cause the actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.
Contact:
CONTACT:
Colm J. King, CEO
Hard To Treat Diseases, Incorporated
(561) 278-7856
htdsotc.com |
